SCHEMBL6945442

SCHEMBL6945442

Oc1ccc(OCCN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
LTA4H P09960 2/20 0.43
SIGMAR1 Q99720 3/20 0.43
HTR1A P08908 2/20 0.43
DRD2 P14416 2/20 0.43
HTR2A P28223 2/20 0.43
HRH1 P35367 2/20 0.43
DRD3 P35462 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
HTR7 P34969 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A3 Q01959 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944676 0.88 TMEM97 (0.52) ESR1ESR2LTA4HSIGMAR1TMEM97
SCHEMBL6947325 0.84 HRH3 (0.43) SIGMAR1HTR1ADRD2HTR2AHRH1
SCHEMBL6945365 0.81 DRD3 (0.46) SIGMAR1HTR1ADRD2HTR2AHRH1
SCHEMBL7397849 0.81 SIGMAR1 (0.62) LTA4HSIGMAR1TMEM97HRH3
SCHEMBL22614716 0.73 SIGMAR1 (0.55) LTA4HSIGMAR1HTR1ADRD2HTR2A
SCHEMBL22614715 0.73 SIGMAR1 (0.55) LTA4HSIGMAR1HTR1ADRD2HTR2A
SCHEMBL22614714 0.73 SIGMAR1 (0.55) LTA4HSIGMAR1HTR1ADRD2HTR2A
SCHEMBL7251610 0.73 LTA4H (0.50) ESR1LTA4HHTR2AHRH3
Hydrochloric Acid SCHEMBL7243161 0.72 LTA4H (0.49) ESR1LTA4HSIGMAR1HTR2AHRH3
SCHEMBL6272657 0.72 CARM1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP claimed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP claimed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed